Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole

Table 6

Mean time to symptom disappearance in the mITT population.

	Patients completing the	Patients reporting	Time to symptom disappearance
	questionnaire	symptom disappearance	(no. of days)
	% (𝑛)	% (𝑛)	Mean ± SD	Median ± SD
Secnidazole	84.4%	82.4%	6.83±0.24^∗	6
(𝑛=243)	(205)	(169)
Metronidazole (𝑛=237)	86.9% (206)	79.6% (164)	7.12±0.25^∗	7

*Difference between treatment groups not statistically significant.